rs147056383
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_001130987.2(DYSF):c.4993G>A(p.Val1665Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000247 in 1,613,842 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V1665V) has been classified as Likely benign.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuromuscular disease caused by qualitative or quantitative defects of dysferlinInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- autosomal recessive limb-girdle muscular dystrophy type 2BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- distal myopathy with anterior tibial onsetInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathy, Paradas typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Miyoshi myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001130987.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DYSF | NM_001130987.2 | MANE Select | c.4993G>A | p.Val1665Ile | missense | Exon 45 of 56 | NP_001124459.1 | ||
| DYSF | NM_003494.4 | MANE Plus Clinical | c.4876G>A | p.Val1626Ile | missense | Exon 44 of 55 | NP_003485.1 | ||
| DYSF | NM_001130981.2 | c.4990G>A | p.Val1664Ile | missense | Exon 45 of 56 | NP_001124453.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DYSF | ENST00000410020.8 | TSL:1 MANE Select | c.4993G>A | p.Val1665Ile | missense | Exon 45 of 56 | ENSP00000386881.3 | ||
| DYSF | ENST00000258104.8 | TSL:1 MANE Plus Clinical | c.4876G>A | p.Val1626Ile | missense | Exon 44 of 55 | ENSP00000258104.3 | ||
| DYSF | ENST00000409582.7 | TSL:1 | c.4990G>A | p.Val1664Ile | missense | Exon 45 of 56 | ENSP00000386547.3 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152224Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000736 AC: 185AN: 251312 AF XY: 0.000670 show subpopulations
GnomAD4 exome AF: 0.000233 AC: 341AN: 1461500Hom.: 3 Cov.: 31 AF XY: 0.000242 AC XY: 176AN XY: 727066 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000381 AC: 58AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1Benign:2
See Variant Classification Assertion Criteria.
DYSF: BS1
not specified Benign:3
Variant summary: DYSF c.4876G>A (p.Val1626Ile) results in a conservative amino acid change located in the C2 domain (IPR000008) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00074 in 251312 control chromosomes, predominantly at a frequency of 0.0096 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 3-fold of the estimated maximal expected allele frequency for a pathogenic variant in DYSF causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.0031), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. It has also been reported at a frequency of 0.0044 in control individuals of Japanese ancestry in the Japanese Whole Genome Reference Panel (ToMMo 38KJPN), including 3 homozygotes. c.4876G>A has been reported in the literature in individuals of East Asian ancestry affected with or suspected of Limb-Girdle Muscular Dystrophy/Dysferlinopathy, without strong evidence for pathogenicity, including one case where it was found in cis with a pathogenic variant, providing supporting evidence for a benign role (e.g. Yu_2017, Liu_2018, Zhong_2021). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 with conflicting assessments. The majority classified the variant as benign (n=1)/likely benign (n=4), two classified the variant as VUS, and one as pathogenic. Based on the evidence outlined above, the variant was classified as benign.
Autosomal recessive limb-girdle muscular dystrophy type 2B Uncertain:1Benign:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin Uncertain:1Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
DYSF-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at